Literature DB >> 18709462

Cognitive functions and the state of nonspecific brain systems in panic disorders.

S A Gordeev1.   

Abstract

A total of 93 patients with panic disorders and 36 healthy control subjects were studied. Clinical-neurological, psychometric, neuropsychological, and neurophysiological (auditory cognitive evoked potentials) investigations were performed. Patients with typical panic disorders were characterized by increased levels of anxiety and depression, along with impairments to cognitive functions in the form of decreases in short-term memory and attention, as compared with healthy subjects. Patients with atypical panic disorders differed from patients with typical panic disorders in having lower levels of anxiety, more severe depression, and more marked cognitive disorders. As compared with healthy subjects, patients with atypical panic disorders showed reductions in the amplitude of the P300 evoked potential wave, while patients with typical panic disorders showed increases. It is suggested that changes in the amplitude parameters of the P300 wave are associated with dysfunction of the limbic-reticular structures of the brain in patients with panic disorders.

Entities:  

Mesh:

Year:  2008        PMID: 18709462     DOI: 10.1007/s11055-008-9036-z

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  24 in total

1.  P300 and response time from a manual Stroop task.

Authors:  A B Ilan; J Polich
Journal:  Clin Neurophysiol       Date:  1999-02       Impact factor: 3.708

2.  The N200 abnormalities of auditory event-related potentials in patients with panic disorder.

Authors:  Jijun Wang; Hiroshi Miyazato; Maxine Randall; Hiroto Hokama; Ken-Ichi Hiramatsu; Chikara Ogura
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-09       Impact factor: 5.067

3.  Auditory event-related potentials in panic disorder.

Authors:  A Iwanami; H Isono; Y Okajima; K Kamijima
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

Review 4.  Selective attention, cortical evoked responses, and brain function in human subjects: a critical review and theory.

Authors:  S R Sabat
Journal:  Biol Psychol       Date:  1978-11       Impact factor: 3.251

5.  P300 assessment of early Alzheimer's disease.

Authors:  J Polich; C Ladish; F E Bloom
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1990 May-Jun

6.  Cognitive deficits in obsessive-compulsive disorder on tests of frontal-striatal function.

Authors:  R Purcell; P Maruff; M Kyrios; C Pantelis
Journal:  Biol Psychiatry       Date:  1998-03-01       Impact factor: 13.382

7.  Auditory event-related potentials in panic and generalised anxiety disorders.

Authors:  Tayfun Turan; Ertugrul Esel; Fatih Karaaslan; Mustafa Basturk; Aslan Oguz; Ihsan Yabanoglu
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-01       Impact factor: 5.067

8.  Subcortical neuronal correlates of component P300 in man.

Authors:  J D Kropotov; V A Ponomarev
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1991-01

9.  A subcortical correlate of P300 in man.

Authors:  C D Yingling; Y Hosobuchi
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1984-02

Review 10.  Anatomical MRI findings in mood and anxiety disorders.

Authors:  Paolo Brambilla; Francesco Barale; Edgardo Caverzasi; Jair Constante Soares
Journal:  Epidemiol Psichiatr Soc       Date:  2002 Apr-Jun
View more
  3 in total

1.  Smaller volume of right hippocampal CA2/3 in patients with panic disorder.

Authors:  Masao Takaishi; Takeshi Asami; Haruhisa Yoshida; Ryota Nakamura; Asuka Yoshimi; Yoshio Hirayasu
Journal:  Brain Imaging Behav       Date:  2021-02       Impact factor: 3.978

2.  Meta-analysis of P300 waveform in panic disorder.

Authors:  Aaron S Howe; Antonio Pinto; Vincenzo De Luca
Journal:  Exp Brain Res       Date:  2014-06-19       Impact factor: 1.972

Review 3.  Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy.

Authors:  Mark J Millan; Yves Agid; Martin Brüne; Edward T Bullmore; Cameron S Carter; Nicola S Clayton; Richard Connor; Sabrina Davis; Bill Deakin; Robert J DeRubeis; Bruno Dubois; Mark A Geyer; Guy M Goodwin; Philip Gorwood; Thérèse M Jay; Marian Joëls; Isabelle M Mansuy; Andreas Meyer-Lindenberg; Declan Murphy; Edmund Rolls; Bernd Saletu; Michael Spedding; John Sweeney; Miles Whittington; Larry J Young
Journal:  Nat Rev Drug Discov       Date:  2012-02-01       Impact factor: 84.694

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.